[Informe de investigación]Se espera que el mercado de dispositivos hiperplásicos prostáticos benignos crezca de 2.078,78 millones de dólares en 2021 a 3.467,31 millones de dólares en 2028; se estima que crecerá a una tasa compuesta anual del 7,6 % entre 2022 y 2028.
La hiperplasia prostática benigna (HPB) es un agrandamiento de la próstata causado por un crecimiento excesivo de células en la próstata. La HPB es una afección benigna (no cancerosa) de la próstata. Las enfermedades no cancerosas no suelen ser mortales y no se propagan (hacen metástasis) a otras partes del cuerpo. La HPB no aumenta el riesgo de cáncer de próstata; A menos que manifieste síntomas, la HPB no se considera un problema de salud. Casi todos los hombres tendrán cierto crecimiento de la próstata a los 70 años. Envejecer, tener más grasa abdominal (también conocida como obesidad abdominal) y no hacer suficiente ejercicio aumentan el riesgo de desarrollar HPB.
El El mercado de dispositivos hiperplásicos prostáticos benignos está segmentado por producto, tipo de procedimiento, usuario final y geografía. Por geografía, el mercado está ampliamente segmentado en América del Norte, Europa, Asia Pacífico, Medio Oriente y Asia. África y el Sur y el Sur. Centroamérica. Este informe ofrece información y un análisis en profundidad del mercado, enfatizando parámetros como las tendencias del mercado, la dinámica del mercado y el análisis competitivo de los principales actores del mercado a nivel mundial.
< h3>Perspectivas estratégicasregiones lucrativas para el mercado de dispositivos hiperplásicos prostáticos benignos
Perspectivas del mercado
Aumento de la prevalencia de la hiperplasia prostática benigna junto con factores de riesgo crecientes y un aumento de las inversiones, fondos y subvenciones para la investigación en el tratamiento de la HPB para impulsar el mercado de dispositivos hiperplásicos prostáticos benignos.
Según el Centro Nacional de Información Biotecnológica (NCBI), la HPB es uno de los trastornos más comunes en hombres mayores y la principal causa de síntomas del tracto urinario inferior (STUI). Después de los 40 años, la prevalencia de la HPB aumenta, alcanzando un máximo del 60% a los 90 años. Según estudios de autopsias, la prevalencia histológica de la HPB es del 8%, 50% y 80% en el cuarto, sexto, y novena décadas de la vida de un hombre, respectivamente. También se ha demostrado que la vejez es un factor de riesgo para la aparición y progresión de la HPB clínica en estudios observacionales realizados en Europa, EE. UU. y Asia. Según las estadísticas del Estudio Longitudinal sobre el Envejecimiento de Krimpen y Baltimore, la próstata crece a un ritmo del 2,0% al 2,5% por año en los hombres mayores. El agrandamiento continuo de la próstata es un factor de riesgo para desarrollar STUI, y las próstatas más grandes se asocian con un agrandamiento prostático benigno (BPE), que desencadena el riesgo de desarrollar HPB clínica e incontinencia urinaria.
Según datos del NCBI, el aumento Se ha descubierto que la adiposidad tiene una correlación positiva con el volumen de la próstata. En numerosos grupos de estudio, se ha observado que el peso corporal, el índice de masa corporal (IMC) y la circunferencia de la cintura tienen una correlación positiva con el volumen de la próstata. Además, los datos epidemiológicos muestran que la obesidad puede aumentar la necesidad de una cirugía para la HPB y de iniciar un tratamiento para la HPB.
Según el American Journal of Men's Health (AJMH), en 2019, a nivel mundial, hubo 11,26 millones de casos nuevos y 1,86 millones de casos. millones de años vividos con discapacidad (AVD) debido a la HPB en 2019. La incidencia de la HPB aumentó un 105,7 % y los AVD aumentaron un 110,6 % en todo el mundo entre 1990 y 2019. La incidencia absoluta y las cifras de AVD aumentaron considerablemente en todo el mundo durante este período, principalmente debido al aumento de la población y al envejecimiento. Según las estimaciones de la FUNDACIÓN DE UROLOGÍA, en el Reino Unido, la prevalencia de la HPB aumenta del 50 % entre los hombres de 50 a 60 años al 90 % entre los hombres de 80 años o más. Algunos hombres desarrollan retención aguda repentina, es decir, incapacidad para orinar. La opción de tratamiento para la HPB incluye cirugías como la resección transuretral de la próstata (TURP), prostatectomía abierta y tratamientos mínimamente invasivos como la ablación transuretral con aguja (TUNA). En tratamientos mínimamente invasivos como la ablación por radiofrecuencia, la terapia con láser y los implantes, se utilizan dispositivos hiperplásicos prostáticos benignos. Por lo tanto, el aumento de la prevalencia de la hiperplasia prostática benigna y el aumento de los factores de riesgo están impulsando la demanda de dispositivos hiperplásicos prostáticos benignos.
Perspectivas del producto
Basado en producto, el mercado de dispositivos hiperplásicos prostáticos benignos se segmenta en resectoscopios, dispositivos de ablación por radiofrecuencia, láseres de urología, stents prostáticos e implantes. Es probable que el segmento de resectoscopios tenga la mayor participación de mercado en 2022. Sin embargo, se prevé que el segmento de láseres de urología registre la CAGR más alta durante el período de pronóstico debido a la alta demanda por parte de los médicos y las crecientes iniciativas de los actores del mercado en el lanzamiento y el producto. expansión.
Mercado de dispositivos hiperplásicos prostáticos benignos, por producto: 2022 y 2028
Información sobre el tipo de procedimiento
Según el tipo de procedimiento, el mercado de dispositivos hiperplásicos prostáticos benignos se segmenta en terapia transuretral con microondas y resección transuretral de la próstata , ablación transuretral con aguja de la próstata, cirugía con láser, cirugía urolift y otras. En 2022, es probable que la resección transuretral del segmento de próstata ocupe la mayor cuota de mercado. Además, se espera que el mismo segmento sea testigo de un crecimiento en su demanda a la CAGR más rápida de 2022 a 2028, debido a su acceso visual y práctico a la próstata, su capacidad de eliminación inmediata del exceso de tejido y la capacidad de resección transuretral de la próstata. próstata (RTUP) para combinar con otros procedimientos.
Información del usuario final
Según el usuario final, el mercado de dispositivos hiperplásicos prostáticos benignos se segmenta en hospitales, clínicas, centros quirúrgicos ambulatorios y otros. En 2022, es probable que el segmento de hospitales tenga la mayor participación del mercado. Además, se espera que el segmento de clínicas experimente un crecimiento en su demanda a la CAGR más rápida de 2022 a 2028, debido a un aumento en el número de clínicas a un menor costo de tratamiento, fácil accesibilidad y flexibilidad con el corto tiempo de espera. /p>
Los desarrollos orgánicos, como los lanzamientos y aprobaciones de productos, son estrategias altamente adoptadas por los actores del mercado global de dispositivos hiperplásicos prostáticos benignos. A continuación se enumeran algunos de los recientes desarrollos clave del mercado:
- En abril de 2022, Teleflex Incorporated lanzó el sistema UroLift en Japón para el tratamiento de la HPB o el agrandamiento de la próstata. El sistema estuvo disponible para su compra inmediatamente después del lanzamiento.
- En abril de 2020, Olympus anunció la aprobación de iTind, su dispositivo médico no quirúrgico, para la cirugía mínimamente invasiva de la HPB. Este es un dispositivo de apertura uretral temporal al que la FDA le ha otorgado una clasificación De Novo y es un dispositivo médico de Clase II.
Mercado de dispositivos hiperplásicos prostáticos benignos: segmentación
El mercado mundial de dispositivos hiperplásicos prostáticos benignos se segmenta por producto, tipo de procedimiento, usuario final y geografía. Según el producto, el mercado se segmenta en resectoscopios, dispositivos de ablación por radiofrecuencia, láseres de urología, stents prostáticos e implantes. Según el tipo de procedimiento, el mercado se segmenta en terapia transuretral con microondas, resección transuretral de la próstata, ablación transuretral con aguja de la próstata, cirugía láser, cirugía urolift y otras. Según el usuario final, el mercado se diferencia en hospitales, clínicas, centros quirúrgicos ambulatorios y otros. Por geografía, el mercado está segmentado en América del Norte, Europa, Asia Pacífico, Medio Oriente y Asia. África y el Sur y el Sur. Centroamérica.
Mercado de dispositivos hiperplásicos prostáticos benignos: perfiles de la empresa
- KARL STORZ SE & Co. KG
- Richard Wolf GmbH
- Olympus Corporation
- Urologix, LLC.
- Boston Scientific Corporation
- Butterfly
- TELEFLEX Incorporated
- OmniGuide Holdings, Inc.
- Tecnologías láser convergentes
- ProArc
- Olympus Corporation
Report Coverage
Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends
Segment Covered
This text is related
to segments covered.
Regional Scope
North America, Europe, Asia Pacific, Middle East & Africa, South & Central America
Country Scope
This text is related
to country scope.
Frequently Asked Questions
The global benign prostatic hyperplasic devices market based on product is resectoscopes, radiofrequency ablation devices, urology laser, prostatic stents, and implants. The resectoscopes segment is likely to hold the largest share of the market in 2022. However, the urology lasers segment is anticipated to register the highest CAGR of 8.4% in the market during the forecast period.
The benign prostatic hyperplasic devices market majorly consists of the players such as KARL STORZ SE & Co. KG; Richard Wolf GmbH; Olympus Corporation; Urologix, LLC.; Boston Scientific Corporation; Butterfly; TELEFLEX Incorporated; OmniGuide Holdings, Inc.; Convergent Laser Technologies; ProArc; and Olympus Corporation.
The factors that are driving and restraining factors that will affect the benign prostatic hyperplasic devices market in the coming years. Factors such as the rise in the prevalence of benign prostatic hyperplasia amongst men, along with increasing risk factors and rise in investments, funds, and grants for research in BPH treatment. However, less awareness about prostate health among men will hamper the market growth.
Benign prostatic hyperplasia (BPH) is a prostate enlargement caused by excessive cell growth in the prostate. BPH is a benign (non-cancerous) prostate condition. Non-cancerous conditions are not usually fatal and do not spread (metastasize) to other body parts. BPH doesn't raise the risk of prostate cancer; unless it manifests symptoms, BPH isn't considered a health issue. Almost all men will have some prostate growth by the age of 70. Getting older, having more belly fat (also known as abdominal obesity), and not getting enough exercise to raise the risk of developing BPH.
The List of Companies - Benign Prostatic Hyperplasic Devices Market
- KARL STORZ SE & Co. KG
- Richard Wolf GmbH
- Olympus Corporation
- Urologix, LLC.
- Boston Scientific Corporation
- Butterfly
- TELEFLEX Incorporated
- OmniGuide Holdings, Inc.
- Convergent Laser Technologies
- ProArc
- Olympus Corporation
The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.
- Data Collection and Secondary Research:
As a market research and consulting firm operating from a decade, we have published and advised several client across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.
Several associations trade associates, technical forums, institutes, societies and organization are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in last 3 years are scrutinized and analyzed to understand the current market trends.
- Primary Research:
The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.
For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.
A typical research interview fulfils the following functions:
- Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
- Validates and strengthens in-house secondary research findings
- Develops the analysis team’s expertise and market understanding
Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:
- Industry participants: VPs, business development managers, market intelligence managers and national sales managers
- Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.
Below is the breakup of our primary respondents by company, designation, and region:
Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.
- Data Analysis:
Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.
- Macro-Economic Factor Analysis:
We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.
- Country Level Data:
Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.
- Company Profile:
The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.
- Developing Base Number:
Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.
- Data Triangulation and Final Review:
The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.
We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.
We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.
Related Reports
Jul 2022
Colonoscopes Market
Forecast to 2028 - COVID-19 Impact and Global Analysis By Product Type (Fiber Optic Colonoscopy Devices, Video Colonoscopy Devices); Application (Colorectal Cancer, Lynch Syndrome, Ulcerative Colitis, Crohn's Disease, Polyp); End User (Hospitals, Ambulatory Surgery Center, Others), and Geography
Jul 2022
Noninvasive Fat Reduction Market
Size and Forecast (2021 - 2031), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Technology (Cryolipolysis, Laser Lipolysis, Ultrasound, and Others), End User (Hospitals, Dermatology Clinics & Cosmetic Clinics, and Others), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America)
Jul 2022
Medical Ultrasound Flow Meter Market
Size and Forecast (2020 - 2030), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Implementation Type (Clamp-On, Inline, and Others), Technology (Doppler, Transit Time, and Hybrid), Application (Heart and Lung Machines, Extracorporeal Membrane Oxygenation, Perfusion, Organ Transportation Systems, and Others), End User (Hospitals and Clinics, Ambulatory Surgical Centers, Research Laboratories, and Others), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America)
Jul 2022
Rapid Test Kits Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Type (Rapid Antigen Testing, Rapid Antibody Testing, and Others), Product (Over-the-Counter Rapid Testing Kit and Professional Rapid Testing Kit), Technology (Lateral Flow Assay, Solid Phase, Agglutination, Immunospot Assay, and Cellular Component-Based), Application (Blood Glucose Testing, Infectious Disease Testing, Pregnancy and Fertility, Cardiometabolic Testing, and Others), End User (Hospital and Clinics, Home Care, Diagnostics Centers, and Others), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America)
Jul 2022
Osteoarthritis Therapy Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Therapy Type [Transcutaneous Electrical Nerve Stimulation (TENS), Occupational Therapy, Physical Therapy, Platelet-Rich Plasma Therapy and Stromal Vascular Fraction, Prolotherapy, and Others], Disease Indication (Knee Osteoarthritis, Spine Osteoarthritis, Foot and Ankle Osteoarthritis, Shoulder Osteoarthritis, Hand Osteoarthritis, and Others), End User (Hospitals & Clinics, Specialty Clinics, Ambulatory Surgical Centers, Homecare, and Others), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America)
Jul 2022
Bariatric Surgeries Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Type [Adjustable Gastric Bands (AGB), Sleeve Gastrectomy, Gastric Bypass, Biliopancreatic Diversion with Duodenal Switch (BPD-DS), and Others], End User (Hospitals and Ambulatory Surgical Centers), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America)
Jul 2022
Post-Acute Care Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Service Type (Skilled Nursing Facilities, Inpatient Rehabilitation Facilities, Long-Term Care Hospitals, Home Health Agency, and Others), Age (Elderly, Adult, and Others), Disease Conditions (Amputations, Wound Management, Brain Injury and Spinal Cord Injury, Neurological Disorders, and Others), and Geography
Jul 2022
Lung Cancer Therapy Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Therapy Type (Noninvasive and Minimally Invasive), Indication (Non-Small Cell Lung Cancer and Small Cell Lung Cancer), End User (Hospitals, Oncology Clinics, Research Centers, and Others), and Geography (North America, Europe, Asia Pacific, South & Central America, and Middle East & Africa)